Jennifer Stacey

Jennifer Stacey has over 20 years of clinical research experience ranging from biomarker and target discovery to strategic conduction of drug development programs. Prior to joining TriNetX, Jennifer held scientific positions at Cell Signaling Technology, Citeline, and inVentiv Health. She received her BS in Biology/Pre-Medicine from St. Lawrence University.